Journal Article

Effect of <i>hMSH6</i> cDNA expression on the phenotype of mismatch repair-deficient colon cancer cell line HCT15

Teresa Lettieri, Giancarlo Marra, Gabriele Aquilina, Margherita Bignami, Nigel E.A. Crompton, Fabio Palombo and Josef Jiricny

in Carcinogenesis

Volume 20, issue 3, pages 373-382
Published in print March 1999 | ISSN: 0143-3334
Published online March 1999 | e-ISSN: 1460-2180 | DOI: http://dx.doi.org/10.1093/carcin/20.3.373
Effect of hMSH6 cDNA expression on the phenotype of mismatch repair-deficient colon cancer cell line HCT15

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics

GO

Show Summary Details

Preview

Mismatch recognition in human cells is mediated primarily by a heterodimer of hMSH2 and hMSH6. Cells mutated in both alleles of the hMSH6 gene are deficient in the correction of base/base mispairs and insertion/deletion loops of one nucleotide and thus exhibit a strong mutator phenotype, evidenced by elevated mutation rates and microsatellite instability, as well as by tolerance to methylating agents. The decrease in replication fidelity associated with a loss of mismatch correction implies that with each division, these cells are likely to acquire new mutations throughout their genomes. Should such secondary mutations occur in genes linked to replication fidelity or involved in the maintenance of genomic stability, they might contribute to the observed mutator phenotype. The human colon tumour line HCT15 represents one such case. Although it carries inactivating mutations in both hMSH6 alleles, it has also been shown to contain a missense mutation in the coding sequence of the proofreading domain of the polymerase-δ gene. In an attempt to find out whether the phenotype of HCT15 cells was indeed brought about solely by the lack of hMSH6, we stably transfected them with a vector carrying the wild-type hMSH6 cDNA. Our results show that although the levels of transgenic hMSH6 were low, expression of the wild-type protein resulted in a substantial restoration of mismatch binding, mismatch repair capacity and the stability of mononucleotide repeats, as well as in the reduction of mutation rates. Although methylation tolerance of the hMSH6-expressing cells was not markedly affected, the G2 cell cycle checkpoint, absent in N-methyl-N′-nitro-N-nitrosoguanidine-treated control cells, was restored.

Keywords: BrdU, 5-bromo-2′-deoxyuridine; DMEM, Dulbecco's modified Eagle's medium; DMSO, dimethylsulphoxide; DTT, dithiothreitol; HNPCC, hereditary non-polyposis colon cancer; HU, hydroxyurea; IDL, insertion/deletion loop; MGMT, O6-methylguanine methyltransferase; MNNG, N-methyl-N′-nitro-N-nitrosoguanidine; MNU, N-methyl-N-nitrosourea; PBS, phosphate-buffered saline; PMSF, phenylmethylsulphonyl fluoride; pol, polymerase; RER, replication error in repeats; 6-TG, 6-thioguanine.

Journal Article.  8493 words.  Illustrated.

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.